Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Sun Pharma reports Q4FY20 results

Posted On: 2020-05-27 21:03:56

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) reported financials for the fourth quarter & full year ending March 31st, 2020.

Highlights of Q4FY20 consolidated financials

- Sales / Income from operations at Rs. 8,078 crores, a growth of about 15% over same quarter last year.

- India sales at Rs. 2,365 crores for Q4FY20. Sales for same period last quarter include a one-time impact of approximately Rs. 1,085 crores related to the change in distribution for India business. Adjusted for this impact, India sales have grown 8% YoY for the quarter.

- US finished dosage sales at US$ 375 million, decline of 15% over same quarter last year. Sales for Q4 last year included a one-time contribution from the special business in US and hence the numbers are not strictly comparable.

- Emerging Markets sales at US$ 187 million, up by 8% over Q4 last year.

- Rest of World sales at US$ 155 million, up by 1% over Q4 last year.

- R&D investments at Rs. 536 crores (6.6% of sales) compared to Rs. 567 crores for Q4FY19.

- EBITDA at Rs. 1,256 crores, with resulting EBITDA margin of 15.5%. Approximately 50% of the EBITDA margin decline versus Q3FY20 is due to the adverse impact of forex loss in Q4FY20.

- Adjusted net profit for quarter was at Rs. 660 crores excluding the impact of exceptional items of Rs. 260 crores. Reported net profit for Q4FY20 was at Rs. 400 crores.

Highlights of FY20 consolidated financials

- Sales / Income from operations at Rs. 32,325 crores, growth of about 13% over same period last year.

- India sales at Rs. 9,710 crores, up 32% YoY. Excluding the one-time impact mentioned above, the adjusted growth was 15% YoY.

- US finished dosage sales at US$ 1,487 million, decline of 2% over same period last year.

- Emerging Markets sales at US$ 776 million, up by 1% over same period last year.

- Rest of World sales at US$ 638 million, growth of 29% over same period last year. This growth was partly driven by the full year consolidation of Pola Pharma acquisition in Japan.

- EBITDA at Rs. 6,477 crores up by 9% over same period last year, with resulting EBITDA margin of 20%.

- Excluding the exceptional items for both FY20 and FY19, net profit for FY20 was at Rs. 4,026 crores, up approximately 4% over FY19. Reported net profit for FY20 was at Rs. 3,765 crores.

These results were taken on record by the Board of Directors at a meeting held in Mumbai today. The Board has proposed a final dividend of Re. 1 per share for the full year FY20.

Dilip Shanghvi, Managing Director of the Company said, "I am happy to see that we are able to maintain business continuity in these challenging times, so that patients continue to get access to their much needed medications. We are also supporting various Governments in their efforts to combat Covid-19. In terms of business performance, we have done well and have started gaining market share in India. Our global specialty business has also gained reasonable traction with Ilumya recording approximately US$ 94 million sales globally in the first full year of commercialization. Our endeavor will be to gain market share in each of our businesses by doing better, despite the near term uncertainties related to Covid-19."

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.450.55 as compared to the previous close of Rs. 459.05. The total number of shares traded during the day was 401190 in over 9820 trades.

The stock hit an intraday high of Rs. 467.4 and intraday low of 443.1. The net turnover during the day was Rs. 182675348.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

ICICI Prudential Life Insurance Company Ltd board to approve 1st quarter FY21 results on July 21, 2020

Sharika Enterprises Ltd bags order from BHEL

Swelect Energy Systems Limited board recommends final dividend of Rs. 0.75

SpiceJet facilitates insurance of passengers for COVID-19 hospitalisation starting at Rs. 443/-

Shoppers Stop Limited opens new store at Phoenix Palassio - Lucknow

PI Industries Ltd closes QIP, fixes price as Rs. 1470

YES Bank has sold 2.66% stake in CG Power & Industrial Solutions Limited

NMDC's excellent performance at Bailadila Projects, Chhattisgarh, during lockdown

The Phoenix Mills Ltd. opens doors of its grand palatial shopping mall, Phoenix Palassio, in Lucknow

Swelect Energy Systems Ltd Q4 consolidated loss at Rs. 14.87 crore

Automotive Stampings and Assemblies Ltd reports loss in Q4 FY2020

SKY Industries Ltd posts loss of Rs. 0.63 crore in Q4 FY2020

SKY Industries Ltd board recommends final dividend of Rs. 0.50 for FY20

IndiGo repatriated 39 Indian nationals from Columbia, in coordination with Qatar Airways

Kokuyo Camlin Ltd Q4 FY20 loss at Rs. 0.34 crore

Muthoot Finance launches Loan@Home service

Mphasis named one of the UK's Top 50 fastest-growing Indian companies

NCC receives 5 new orders totalin Rs. 1396 crore in June 2020

Nestlé India reaches out to Youth-launches 1000 'Nesternship' opportunities for young professionals

Bharat Forge launches Health Risk Monitoring System (HRMS) - An AI platform enabling Safe return to Workplace

Heritage Foods Ltd board to consider Q1FY21 results on July 29, 2020

Intellect Digital Core (IDC) ranked world #1 by IBS Intelligence Annual Sales League Table 2020

Ambuja Cements Ltd board to consider 2nd quarter results on July 24, 2020

RBL Bank revamps 'RBL MyCard' credit card app

Thomas Cook India sees opportunity in demand for mini-breaks Introduces City Escapes

TCS Launches Quartz™ Smart Solution to Help Financial Institutions Offer Cryptocurrency Trading

Tactical Air Support selects Ramco Aviation Suite

Karur Vysya Bank and Bajaj Allianz Life Insurance announce strategic partnership

Tractor market to report strong growth in Q2 FY21 - Pritika Auto Industries Ltd

LTI Launches Canvas, a Modern Software Engineering Platform for Remote & Hybrid Workforce of Future

ITC facilitates creation of livelihood opportunities in the rural sector during the pandemic

ABB launches anti-bacterial switches and sockets to keep surroundings safe

Steel Strips Wheels Ltd receives $140K alloy wheels order from EU market

Nucleus FinnOne Neo recognized as the #1 Market Leader in Lending by IBS Intelligence

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg due to the detection of NDMA impurity

ICRA reaffirms long term rating of Puravankara Ltd

YES Bank Ltd board approves fund raising through FPO

GMR Infrastructure Ltd. announces the Completion of Strategic Partnership transaction with Groupe ADP for Airports Business

Infosys Ltd board to announce Q1FY21 results on July 15, 2020

Shree Renuka Sugars Ltd Q4 consolidated loss at Rs. 146 crore

ZIM announces submission of marketing authorization application for Rizatriptan orally dissolving film in Europe

KG Petrochem Ltd Q4 FY20 net profit jumps to Rs. 10.64 crore

Airtel launches NEW Prepaid Packs with Premium Content from ZEE5

Birlasoft partners with Innoveo to Fast-track the Journey to Digital Excellence

PPAP Automotive Limited receives award from Toyota Kirloskar Motor Pvt Ltd

Indian Acrylics Ltd Q4 FY20 PAT at Rs. 3.45 crore

India Infrastructure Trust board Declares total distribution of Rs. 4.4497

Best Agrolife Ltd Board approves final dividend of Rs. 0.10 for FY2020

A Infrastructure Ltd Board approves Dividend of Rs. 0.10 for FY20

Unichem Laboratories Limited receives ANDA approval for its Cyclobenzaprine Hydrochloride Tablets

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019